Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-05-13
2009-02-17
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S009100, C424S009200, C424S193100, C424S204100, C424S234100, C424S278100
Reexamination Certificate
active
07491395
ABSTRACT:
The present invention provides methods and means for preparing vaccines that are capable of eliciting strong immune responses, especially through intranasal delivery. The invention discloses particles, referred to as “co-micelles,” in which antigens are present that interact through hydrophobic interactions with certain specific types of amphiphilic compounds, wherein the amphiphilic compounds have adjuvant activity and wherein the antigens are preferably antigenic surface proteins, such as integral membrane proteins from infectious agents like viruses.
REFERENCES:
patent: 4900549 (1990-02-01), De Vries et al.
patent: 5565203 (1996-10-01), Gluck et al.
patent: 5879685 (1999-03-01), Gluck et al.
patent: 6338859 (2002-01-01), Leroux et al.
patent: 6733985 (2004-05-01), Lee
patent: 2001/0018054 (2001-08-01), Hanna et al.
patent: 2001/0019715 (2001-09-01), Hanna et al.
patent: 2001/0053368 (2001-12-01), Burt et al.
patent: 2003/0113347 (2003-06-01), Cusi et al.
patent: 2004/0156867 (2004-08-01), Burt et al.
patent: 0 109 942 (1984-05-01), None
patent: 0 231 039 (1987-08-01), None
patent: 0 180 564 (1988-05-01), None
patent: 0 538 437 (1993-04-01), None
patent: WO 88/08718 (1988-11-01), None
patent: WO 92/19267 (1992-11-01), None
patent: WO 99/13912 (1999-03-01), None
patent: WO 99/27954 (1999-06-01), None
patent: WO 00/70084 (2000-11-01), None
patent: WO 01/47553 (2001-07-01), None
patent: WO 01/60402 (2001-08-01), None
patent: WO 02/00194 (2002-01-01), None
patent: WO 2004/045641 (2004-06-01), None
PCT International Search Report, PCT/EP03/13084, dated Nov. 25, 2004.
PCT International Preliminary Examination Report, PCT/EP03/13084, dated Apr. 25, 2005.
PCT Written Opinion, PCT/EP03/13084, Jan. 13, 2005.
Partial European Search Report, EP 02102610.9, dated Sep. 8, 2003.
Ando et al., “Preparation of Influenza Virosome Vaccine with Muramyldipeptide Derivative B30-MDP,” J. Microencapsulation, 1997, pp. 79-90, vol. 14, No. 1.
Baier et al., “Lipopeptides as Immunoadjuvants and Immunostimulants in Mucosal Immunization,” Immunobiology, 2000, pp. 391-405, vol. 201.
Lex et al., “A Synthetic Analogue ofEscherichia coliLipoprotein, Tripalmitoyl Pentapeptide, Constitutes a Potent Immune Adjuvant,” The Journal of Immunology, Oct. 15, 1986, pp. 2676-2681, vol. 137, No. 8.
Schlecht et al., “Enhancement of Protection against Salmonella Infection in Mice Mediated by a Synthetic Lipopeptide Analogue of Bacterial Lipoprotein inS. typhimuriumVaccines,” Zentralblatt fur Bakteriology, Oct. 1989, pp. 493-500, vol. 271, No. 4.
Reitermann et al., “Lipopeptide Derivatives of Bacterial Lipoprotein Consitute Potent Immune Adjuvants Combined with or Covalently Coupled to Antigen or Hapten,” Biol. Chem., Apr. 1989, pp. 343-352, vol. 370, No. 4.
Huber et al., “Modulation of the Th 1/ Th 2 Bias by Lipopeptide and Saponin Adjuvants in Orally Immunized Mice,” Immunobiol., Mar. 2002, pp. 61-73, vol. 205, No. 1.
Erdile et al., “OspA lipoprotein ofBorrelia burgdorferiis a mucosal immunogen and adjuvant,” Vaccine, 1997, pp. 988-996, vol. 15, No. 9.
Bron et al., “Preparation, Properties, and Applications of Reconstituted Influenza Virus Envelopes (Virosomes),”0 Methods in Enzymology, 1993, pp. 313-331, vol. 220.
Encyclopedia of Chemical Technology, Fourth Edition, 1995, pp. 55, vol. 15, John Wiley & Sons, USA.
Encyclopedia of Chemical Technology, Fourth Edition, 1997, pp. 488-491, vol. 23, John Wiley & Sons, USA.
Bestewil Holding B.V.
Swartz Rodney P.
TraskBritt
LandOfFree
Compositions comprising antigen-complexes, method of making... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising antigen-complexes, method of making..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising antigen-complexes, method of making... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059762